Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2014-06-10
Original market date: See footnote 1
1998-10-13
Product name:
TISSEEL KIT VH 1.0
DIN:
02233273
Product Monograph/Veterinary Labelling:
Date:
2011-12-20
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BAXTER AG
Industriestrasse 67
Vienna
Saone Et Loire
Austria
1220
Class:
Human
Dosage form(s):
Powder For Solution , Kit , Liquid
Route(s) of administration:
Topical
Number of active ingredient(s):
9
Schedule(s):
Schedule D , Prescription
American Hospital Formulary Service (AHFS): See footnote 3
20:28.16
Anatomical Therapeutic Chemical (ATC): See footnote 4
B02BD20 COMBINATIONS
Active ingredient group (AIG) number:See footnote5
0936991008
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| APROTININ (BOVINE) | 3000 KIU / 1 ML |
| CALCIUM CHLORIDE | 40 MCMOL / 1 ML |
| FACTOR XIII | 50 UNIT / 1 ML |
| FIBRINOGEN (HUMAN) | 110 MG / 1 ML |
| PLASMAFIBRONECTIN (CIG) | 9 MG / 1 ML |
| PLASMINOGEN | 120 MCG / 1 ML |
| THROMBIN (HUMAN) | 4 UNIT / 1 ML |
| THROMBIN (HUMAN) | 500 UNIT / 1 ML |
| TOTAL PROTEIN | 130 MG / 1 ML |